A detailed history of Welch Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Welch Group, LLC holds 9,842 shares of NVS stock, worth $967,960. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,842
Previous 10,226 3.76%
Holding current value
$967,960
Previous $1.09 Million 4.04%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$106.13 - $120.89 $40,753 - $46,421
-384 Reduced 3.76%
9,842 $1.13 Million
Q1 2024

Apr 09, 2024

SELL
$95.27 - $108.47 $52,970 - $60,309
-556 Reduced 5.16%
10,226 $989,000
Q4 2023

Jan 22, 2024

SELL
$92.27 - $101.54 $11,349 - $12,489
-123 Reduced 1.13%
10,782 $1.09 Million
Q3 2023

Oct 18, 2023

SELL
$94.73 - $105.13 $84,120 - $93,355
-888 Reduced 7.53%
10,905 $1.11 Million
Q1 2023

Apr 13, 2023

SELL
$80.03 - $92.81 $105,319 - $122,137
-1,316 Reduced 10.04%
11,793 $1.08 Million
Q4 2022

Jan 27, 2023

SELL
$75.55 - $92.52 $33,846 - $41,448
-448 Reduced 3.3%
13,109 $1.19 Million
Q2 2022

Jul 21, 2022

SELL
$80.52 - $93.75 $111,439 - $129,750
-1,384 Reduced 9.26%
13,557 $1.15 Million
Q1 2022

Apr 29, 2022

SELL
$80.11 - $90.62 $133,303 - $150,791
-1,664 Reduced 10.02%
14,941 $1.31 Million
Q4 2021

Jan 26, 2022

SELL
$79.7 - $88.13 $683,108 - $755,362
-8,571 Reduced 34.04%
16,605 $1.45 Million
Q3 2021

Nov 05, 2021

SELL
$81.78 - $95.14 $29 Million - $33.7 Million
-354,635 Reduced 93.37%
25,176 $2.06 Million
Q2 2021

Jul 21, 2021

BUY
$85.24 - $94.15 $1.37 Million - $1.51 Million
16,047 Added 4.41%
379,811 $34.7 Million
Q1 2021

Apr 23, 2021

BUY
$83.5 - $98.47 $344,354 - $406,090
4,124 Added 1.15%
363,764 $31.1 Million
Q4 2020

Jan 25, 2021

BUY
$78.07 - $94.43 $368,958 - $446,276
4,726 Added 1.33%
359,640 $34 Million
Q3 2020

Oct 28, 2020

BUY
$82.14 - $91.0 $779,097 - $863,135
9,485 Added 2.75%
354,914 $30.9 Million
Q2 2020

Jul 22, 2020

BUY
$80.93 - $91.1 $235,587 - $265,192
2,911 Added 0.85%
345,429 $30.2 Million
Q1 2020

Apr 28, 2020

BUY
$70.67 - $99.01 $1.06 Million - $1.49 Million
15,040 Added 4.59%
342,518 $28.2 Million
Q4 2019

Jan 24, 2020

BUY
$84.35 - $95.37 $263,003 - $297,363
3,118 Added 0.96%
327,478 $31 Million
Q3 2019

Nov 05, 2019

SELL
$85.54 - $94.26 $650,788 - $717,130
-7,608 Reduced 2.29%
324,360 $28.2 Million
Q2 2019

Jul 11, 2019

BUY
$75.4 - $92.8 $2.87 Million - $3.53 Million
38,068 Added 12.95%
331,968 $30.3 Million
Q1 2019

Apr 15, 2019

SELL
$75.32 - $86.15 $131,584 - $150,504
-1,747 Reduced 0.59%
293,900 $28.3 Million
Q4 2018

Jan 10, 2019

BUY
$73.66 - $82.02 $253,537 - $282,312
3,442 Added 1.18%
295,647 $25.4 Million
Q3 2018

Nov 01, 2018

BUY
$66.94 - $77.43 $523,203 - $605,192
7,816 Added 2.75%
292,205 $25.2 Million
Q2 2018

Jul 30, 2018

BUY
$64.91 - $73.36 $636,182 - $719,001
9,801 Added 3.57%
284,389 $21.5 Million
Q1 2018

Apr 23, 2018

BUY
$70.39 - $84.15 $4.96 Million - $5.92 Million
70,401 Added 34.48%
274,588 $22.2 Million
Q4 2017

Feb 01, 2018

SELL
$72.33 - $77.64 $195,146 - $209,472
-2,698 Reduced 1.3%
204,187 $17.1 Million
Q3 2017

Nov 07, 2017

BUY
$74.14 - $77.27 $55,975 - $58,338
755 Added 0.37%
206,885 $17.8 Million
Q2 2017

Aug 07, 2017

BUY
N/A
206,130
206,130 $17.2 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Welch Group, LLC Portfolio

Follow Welch Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.